Cargando…

Long Non-Coding RNAs in Multiple Myeloma

Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells in the bone marrow. While new treatment brought unprecedented increase of survival of patients, MM pathogenesis is yet to be clarified. Increasing evidence of expression of long non-coding RNA molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butova, Romana, Vychytilova-Faltejskova, Petra, Souckova, Adela, Sevcikova, Sabina, Hajek, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468639/ https://www.ncbi.nlm.nih.gov/pubmed/30682861 http://dx.doi.org/10.3390/ncrna5010013

Ejemplares similares

LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients
por: Bútová, Romana, et al.
Publicado: (2021)

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
por: Vlachová, Monika, et al.
Publicado: (2022)

Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development
por: Gregorova, Jana, et al.
Publicado: (2021)

MicroRNAs in urine are not biomarkers of multiple myeloma
por: Sedlaříková, Lenka, et al.
Publicado: (2015)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Long Non-Coding RNAs in Multiple Myeloma
por: Nobili, Lucia, et al.
Publicado: (2018)

Novel classes of non-coding RNAs and cancer
por: Sana, Jiri, et al.
Publicado: (2012)

Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
por: Thorenoor, Nithyananda, et al.
Publicado: (2015)

Long non-coding RNAs in multiple myeloma (Review)
por: Yang, Chenbo, et al.
Publicado: (2023)

The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs
por: Coira, Isabel F., et al.
Publicado: (2022)

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology
por: Raimondi, Lavinia, et al.
Publicado: (2020)

Immunomodulatory Agents for Multiple Myeloma
por: Minařík, Jiří, et al.
Publicado: (2022)

MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion
por: Machackova, Tana, et al.
Publicado: (2020)

Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma
por: Ismail, Nor Hayati, et al.
Publicado: (2023)

High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017)

A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2018)

Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma
por: Dementyeva, Elena, et al.
Publicado: (2013)

Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma
por: Samur, Mehmet Kemal, et al.
Publicado: (2018)

Long Non-Coding RNAs in Kidney Disease
por: Ignarski, Michael, et al.
Publicado: (2019)

Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors
por: Malek, Ehsan, et al.
Publicado: (2016)

TGF-β – an excellent servant but a bad master
por: Kubiczkova, Lenka, et al.
Publicado: (2012)

Identification of patients at high risk of secondary extramedullary multiple myeloma development
por: Stork, Martin, et al.
Publicado: (2021)

The potential of glutamine metabolism-related long non-coding RNAs (lncRNAs) as prognostic biomarkers in multiple myeloma patients
por: Zhong, Yun, et al.
Publicado: (2022)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
por: Stork, Martin, et al.
Publicado: (2022)

Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels
por: Zhang, Xiaopei, et al.
Publicado: (2019)

Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis
por: El Khodiry, Aya, et al.
Publicado: (2018)

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
por: Lulli, Matteo, et al.
Publicado: (2022)

Dynamics of tumor‐specific cfDNA in response to therapy in multiple myeloma patients
por: Vrabel, David, et al.
Publicado: (2019)

On the classification of long non-coding RNAs
por: Ma, Lina, et al.
Publicado: (2013)

Long Non-coding RNAs in the Cytoplasm
por: Rashid, Farooq, et al.
Publicado: (2016)

Long non-coding RNAs in osteosarcoma
por: Chen, Ruiling, et al.
Publicado: (2017)

Long Non-Coding RNAs in Insects
por: Choudhary, Chhavi, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
por: Knight, Andrea, et al.
Publicado: (2021)

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets
por: Steiner, Normann, et al.
Publicado: (2018)

Primate-specific Long Non-coding RNAs and MicroRNAs
por: Awan, Hassaan Mehboob, et al.
Publicado: (2017)

Role of MicroRNAs and Long Non-Coding RNAs in Sarcopenia
por: Lee, Jihui, et al.
Publicado: (2022)

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
por: Detomas, Mario, et al.
Publicado: (2022)

Long Non-Coding RNAs in Haematological Malignancies
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2013)

Long Non-Coding RNAs in Endometrial Carcinoma
por: Smolle, Maria A., et al.
Publicado: (2015)

Long non-coding RNAs in colorectal cancer
por: Xie, Xia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i8epth2bl429m3rmjnfahtmn4q